News

ROSEN, A LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
New York, New York-- (Newsfile Corp. - April 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 ...
TRYVIO/JERAYGO Positioned to Redefine Treatment of Resistant Hypertension | DelveInsight
DelveInsight's "TRYVIO/JERAYGO Market Size, Forecast, and Market Insight Report" highlights the details around TRYVIO/JERAYGO ...
DelveInsight Business Research, LLP: TRYVIO/JERAYGO Positioned to Redefine Treatment of Resistant Hypertension | DelveInsight
TRYVIO (aprocitentan) in the US and JERAYGO in Europe present significant market potential as novel therapies for patients with hypertension inadequately controlled by existing treatments. TRYVIO ...